View Cart  

FDA Finalizes Guidance Supporting Superiority Trials for Acute Bacterial Sinusitis Drugs

Sponsors of clinical studies for antimicrobial drugs to treat acute bacterial sinusitis (ABS) should use superiority trials and demonstrate that the candidate affects the clinical course of the disease, according to finalized FDA guidance on the topic.

To View This Article:


Subscribe To Drug Industry Daily